Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German Final Ordinance Creates 460 DRGs, “Innovation Clause”

This article was originally published in The Gray Sheet

Executive Summary

The final German diagnosis-related group ordinance, published Sept. 25, contains 460 DRGs, 100 less than the draft version

You may also be interested in...



Germany Lures Hospitals To DRGs Despite Modest Implementation Resources

Legislation under consideration in Germany will exclude hospitals joining an optional DRG establishment period in 2003 from a freeze on health care funds, providing hesitant centers an incentive to join the system, according to device association BVMed

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel